Filana Therapeutics (SAVA) Q3 2023 Earnings

7NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.77
-0.67
-0.57
-0.47

Details

Expected EPS
-0.77
Actual EPS
-0.61
Surprise EPS
0.16
Surprise Percent
+20.78%

Description

Filana Therapeutics (SAVA) has reported earnings of -0.61 per share for Q3 2023.

0 Comments

Share your thoughts